|
|||||
|
|

Child care and education company Bright Horizons (NYSE:BFAM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.8% year on year to $733.7 million. On the other hand, the company’s full-year revenue guidance of $3.1 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $1.15 per share was 2.5% above analysts’ consensus estimates.
Is now the time to buy BFAM? Find out in our full research report (it’s free for active Edge members).
Bright Horizons reported fourth quarter results that exceeded Wall Street’s revenue and non-GAAP profit expectations, but the market reacted negatively, reflecting concerns beyond the headline numbers. Management attributed performance to robust growth in its back-up care segment, with CEO Stephen Kramer highlighting a 17% revenue increase driven by both predictable and unexpected care needs. The company also made progress in its U.K. business, achieving positive operating profit after significant losses in recent years, and continued to rationalize its center portfolio to address underperforming locations.
Looking ahead, Bright Horizons’ guidance factors in steady enrollment growth, planned tuition increases, and continued center closures to improve operational efficiency. CFO Elizabeth Boland noted that net center closures will continue in the coming year, with efforts to close 45 to 50 underperforming sites, while new openings remain limited. Management expects the back-up care segment to remain a key growth driver, aiming to expand user penetration within existing clients and leverage employer partnerships. While optimism remains regarding portfolio improvements, the company acknowledged that achieving targeted occupancy rates and margin expansion will be a gradual process.
Management pointed to several major themes driving fourth quarter results and shaping the company’s strategic direction, including continued back-up care momentum, steady progress in enrollment, and actions to streamline the center portfolio.
Bright Horizons’ outlook is shaped by continued growth in back-up care, efforts to improve enrollment and center economics, and ongoing cost pressures tied to labor and benefits.
In the coming quarters, our analysts will be watching (1) the pace and effectiveness of center closures and their impact on profitability, (2) continued growth in back-up care user adoption and frequency within employer clients, and (3) progress toward improving enrollment in underperforming centers. Execution on pricing strategies and the ability to manage labor and benefit costs will also be critical for margin improvement.
Bright Horizons currently trades at $78.15, down from $81.83 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Feb-17 | |
| Feb-16 | |
| Feb-13 | |
| Feb-13 | |
| Feb-13 | |
| Feb-13 | |
| Feb-13 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-10 | |
| Jan-29 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite